Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Feb 25;6(2):e0005838. doi: 10.1371/journal.pgph.0005838

Prevalence and determinants of depression, anxiety, and perceived stress among patients with chronic comorbidity attending outpatient clinics in Addis Ababa during the COVID-19 pandemic

Etsegenet Dege Dires 1, Ayto Addisu Negash 2,*, Getachew W/Yohannes 3, Firdos Ali Mohammed 4, Muna Ahmed Redi 5, Birhanu Fenta Tsega 6, Agazhe Melaku Mihiretie 7, Sifessa Dessalegn Demshasha 8, Tekiy Markos Bedore 2, Yitayew Ewnetu Mohammed 9
Editor: Theingi Maung Maung10
PMCID: PMC12935201  PMID: 41739796

Abstract

The COVID-19 pandemic has disproportionately affected individuals with chronic conditions, increasing risks of severe illness and psychological distress. In Ethiopia, limited healthcare access and disrupted social support have heightened depression, anxiety, and stress, yet evidence on this population remains scarce. This study assessed the prevalence and determinants of depression, anxiety, and perceived stress among patients with chronic comorbidity in Addis Ababa during the COVID-19 pandemic. A cross-sectional study was conducted from April to June 2021 at St. Paul’s Hospital Millennium Medical College and Black Lion Hospital. A total of 437 adults were selected using systematic random sampling, and 426 participants were included in the analysis. Data were collected using Hospital Anxiety and Depression Scale (HADS), the 10-item Perceived Stress Scale (PSS-10-C), and Oslo-3 Social Support Scale. Logistic regression analysis was used to identify factors associated with psychological distress. The mean age of participants was 49.6 years; 52.1% were female. Hypertension, heart disease, and diabetes were the most common chronic conditions, and 46.5% of participants had multiple comorbidities. Severe perceived stress was reported by 45.5% of participants, while depression and anxiety were identified in 39.7% and 26.5% of participants, respectively, based on combined proportion of participants with borderline and abnormal levels on the HADS. Higher psychological distress was associated with younger age, multiple comorbidities, female sex, unmarried status, low education, and poor social support. The findings indicate that the COVID-19 pandemic has amplified mental health challenges among patients with chronic illnesses in Addis Ababa. Integrating targeted psycho-social interventions and conducting longitudinal studies are essential to mitigate long-term mental health impacts of the pandemic.

Introduction

Background of study

The corona-virus disease (COVID-19) emerged in December 2019 and rapidly became a global pandemic, affecting millions worldwide. By December 2020, over 61.8 million confirmed cases and 1.4 million deaths had been reported globally, including 110,554 cases and 1,709 deaths in Ethiopia, one of the low-income countries heavily impacted by the pandemic [1,2]. COVID-19 has had a disproportionate impact on individuals with chronic medical illnesses, who are more vulnerable to severe infection, frequent hospitalization, and death [36].

Beyond its physical effects, the pandemic has created major psychological stressors, particularly for those with chronic comorbidity. Social distancing and lockdown measures have disrupted social support systems and access to routine medical care, exacerbating existing mental health challenges [79]. Isolation and the loss of physical contact, once a vital form of emotional connection, have intensified feelings of distress [8], Limited access to online or e-mental-health services in countries like Ethiopia further restricts coping options, heightening the psychological toll [9].

Even before the pandemic, mental health disorders were common among individuals with chronic illnesses. Depression affected 4–5% of the general population [10] with higher prevalence among those with medical, social, or psycho social risk factors [11]. Studies report that 27–40% of patients with chronic obstructive pulmonary disease (COPD) experience clinically relevant depression [12,13] and up to 36% present with significant anxiety symptoms [13]. Among people with diabetes mellitus (DM), the prevalence of mental disorders ranges from 20% to 55% [9], while 13–17% of cancer patients exhibit depressive symptoms. Such co-morbid psychological conditions are linked to poorer outcomes, including increased morbidity, suicide risk, and reduced quality of life.

During the pandemic, these psychological burdens among patients with chronic diseases have worsened due to fear of infection, uncertainty, self-isolation, and disruptions in healthcare access. Additional stressors, such as financial hardship, unemployment, and overwhelming news exposure, have further contributed to anxiety and depression [14]. Untreated psychological distress, anxiety, and depression may lead to non-adherence to life style modifications and medical treatment, reduced survival, higher healthcare costs, and decreased quality of life [15]. Moreover COVID-19 related stress has even been associated with increased risk of stress cardiomyopathy [16], and worsened pulmonary morbidity [17]. Anxiety and depression also hinder lifestyle modification [18], contribute to hypertension [19], and negatively affect survival in cancer patients [20]. Ensuring continuity of care for patients with chronic diseases is thus vital to prevent an escalation of non-COVID-19-related morbidity and mortality [21].

Ethiopia, with over 116 million people [22], faces major healthcare challenges, including a low doctor-patient ratio [23,24], high treatment costs, and widespread health illiteracy. Social networks, crucial for coping, were disrupted by pandemic restrictions, likely worsening mental health among low-income patients with chronic illnesses.

Despite these compounded challenges, there remains limited research on the psychological impact of the COVID-19 pandemic on this population, making an understanding of the prevalence and determinants of depression, anxiety, and perceived stress essential to inform evidence-based interventions and integrate mental health support into routine chronic disease management.

Objective of the study

This study aims to assess the prevalence and determinants of depression, anxiety, and perceived stress among patients with chronic comorbidities attending outpatient clinics in Addis Ababa during the COVID-19 pandemic.

Materials and methods

Study area, duration, and design

A facility-based cross-sectional study was conducted at Black Lion Hospital and St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. Black Lion Hospital and St. Paul’s Hospital Millennium Medical College (SPHMM) are two of the largest hospitals providing specialty care to patients from Addis Ababa and nationwide [25,26]. The data collection period was from April 10, 2021 to June 30, 2021GC, which corresponds to the early post–first-wave phase of the COVID-19 pandemic in Ethiopia. During this time, national cases peaked in April and declined thereafter, and vaccination had only recently begun, with most of the population still unvaccinated. This context is important for interpreting the findings.

Population

All patients with chronic medical patients aged 18 and above who were on follow up treatment at St. Paul’s hospital millennium medical college and black lion hospital outpatient clinics (renal dialysis, oncology, pulmonology, endocrinology, and cardiology clinic) were the source population. All patients with chronic medical conditions who were on follow up treatment at SPHMM and BLH outpatient departments during the study period were the study population. Patients who declined to be interviewed, and those with existing mental health problems already on treatment at psychiatry OPD were excluded from the study.

Eligibility criteria.

Inclusion Criteria: All patients with comorbidity aged 18 and above who were on follow up treatment at St. Paul’s hospital millennium medical college and black lion hospital OPD during the study period were included.

Exclusion Criteria: Patients who declined to be interviewed were excluded. In addition, critically ill patients or those experiencing acute exacerbation’s of their chronic conditions (such as DKA, HHS, acute asthma attacks, or COPD exacerbation’s) were excluded because acute medical events themselves are significant psychological stressors, making it difficult to accurately attribute psychological distress specifically to the COVID-19 pandemic. Patients with preexisting mental health conditions who were already receiving follow-up care at the psychiatry outpatient department were also excluded to avoid confounding and to ensure that the psychological outcomes assessed reflected new-onset or pandemic-related effects. While these exclusions were necessary for methodological clarity, we acknowledge that they may introduce selection bias and potentially underestimate the true burden of psychological distress among the broader chronic-illness population.

Study variables.

Dependent variables: Depression, Anxiety and Perceived stress level.

Independent variables:

Socio-demographic variables: Age, sex, marital status, place of residence, patient’s occupation, educational level, family size, number of house room, being primary care giver for children or other relatives.

Clinical characteristics and risk assessment of the study participants: - type of chronic diseases, age of onset of chronic illness, duration of chronic disease, number of co-morbidities, physical(social) activity, substance use, presence of respiratory symptoms in the past two weeks, use of a face mask and sanitizer, contact history with known covid-19 case and having social support.

Environmental related concern: - the wide community spread of covid-19, inadequate national response, working in a place where one is susceptible to contract COVID-19 and restriction to engage in several religious festivals, get-together.

Socioeconomic related concern: - Self-isolation or quarantine because of COVID -19 infection, concern about infecting others, difficulty in obtaining help, social support or availability of appropriate care needed, difficulty obtaining food, health care, medicine, or essentials and loss of job or loss of income related to COVID-19.

Health related concern: - Postponement or cancellation of treatment, changes in their health care trajectory, the Possibility that their co-morbid illness may progress or be less likely to be cured due to changes in treatment, getting sick from exposure to COVID-19 and subsequent poorer outcomes during the COVID-19 pandemic and concerned about difficulties in managing their co-morbid illness if they contract COVID-19.

Sampling

Sampling size determination: A single population proportion formula [n = (Z a/2)2 P(1-P)/d2] was used to determine the required sample size. The assumptions used to calculate the sample size were: 95% level of confidence interval (Z α/2 = 1.96), 5% margin of error. Published data in Ethiopia depicted the prevalence of abnormal psychological impact was 22.8% [27], depression 55.7% and anxiety 61.8% among patients with chronic medical condition during COVID-19 pandemic [28]. A prevalence of 55.7% was used to achieve the maximum sample size, based on a similar study conducted during the COVID-19 pandemic. By adding a 15% non-response rate, the final sample size was calculated to be 437 using simple proportion formula.

Sampling technique: The average patient load with comorbidities attending treatment at the two selected tertiary hospital OPDs was estimated over the past three months. Based on these patient loads, the sample size was proportionally allocated between the two hospitals. Within each hospital, the sample was further allocated proportionally across the six selected clinics according to their patient volumes. The sampling interval k was calculated by dividing the total average patient load across both hospitals by the overall sample size, yielding a single, common k value. Data were then collected from eligible patients using a systematic random sampling technique by selecting every kth patient across all clinics and hospitals. This approach ensured consistent and proportional representation of patients throughout the study (Fig 1).

Fig 1. Schematic diagram for sampling procedure.

Fig 1

Data Collection procedures: A pre-tested, structured interviewer administered questionnaires was used for data collection. The Pretest was conducted by taking 5% of the total sample size prior to the actual data collection period in Yekatit 12 Hospital medical college. Data quality was insured by translating the questionnaire from English to Amharic by considering the culture and norms of the society and then back to English to check the consistency. The data was collected by the primary investigator, two general practitioners, one clinical pharmacist and one nurse. The data were collected under regular supervision after giving training for enumerators about the objective of the study, ethical issues, procedures, techniques and ways of collecting the data. Moreover, COVID-19 preventive measures was taken to ensure protection of the data collectors and the respondents at all-time based on the national and global guidance.

Of the 437 participants approached, 426 completed the survey, yielding a response rate of 97.4%. The remaining 11 individuals did not participate due to refusal. Available demographic data (age, sex, and clinic attended) suggested no systematic differences between responders and non-responders, indicating minimal risk of non-response bias.

Data collection tools

The pandemic related perceived stress scale of COVID-19 (PSS-10-C) and Hospital Anxiety and Depression Scale (HADS) are used.

Depression and anxiety were assessed by the Hospital Anxiety and Depression Scale (HADS). This tool has 14 items (seven for each) which, scored in a Likert manner from 0–3, yield a total of 21 points and distinguishes the status of anxiety and depression symptoms. The scale has been validated in different populations in Ethiopia [2831].

The Oslo-3 social support scale was used to measure social support, with a sum of raw scores ranging from 3 to 114. A score was classified as poor, moderate and strong social support in a range of 3–8, 9–11 and 12–14 respectively [32,33].

The pandemic-related Perceived Stress Scale of COVID-19 (PSS-10-C) was used to assess stress specifically associated with the COVID-19 pandemic. Although the scale has been widely applied internationally, it has not yet been formally validated in Ethiopia, which we acknowledge as a limitation. The PSS-10-C consists of 10 items with five response options (“never,” “almost never,” “occasionally,” “almost always,” and “always”). Items 1, 2, 3, 6, 9, and 10 are scored directly from 0 to 4, whereas items 4, 5, 7, and 8 are reverse-scored from 4 to 0 [34,35].

In this study, the PSS-10-C demonstrated satisfactory internal consistency (Cronbach alpha = 0.783). Item–total correlation analysis showed that all items had acceptable values (>0.30), indicating that none of the items performed poorly or required removal.

Operational definition

Level of depression and anxiety: The 14 item questionnaires using the hospital anxiety and depression scale (HADS) cut-off point was used to determine anxiety and depression level. The (HADS) questionnaire has been well validated. A score of 8/21 is cut-off point for anxiety and depression. The total HADS score is divided into less than 8 (normal), 8–10 (borderline or mild), and 11–21 (abnormal or case) [2831].

The level of social support was assessed based on 3 item questionnaires using the OSLO social support scale. The OSLO social support scale questionnaire has been well validated. The total score is divided into 3–8 (poor social support), 9–11 (moderate social support), and 1214 (strong social support) [32], [33].

The level of COVID-19 related perceived stress: pandemic related perceived stress score cut-off point 27 was used to categorize participants under high perceived stress (≥ 27). Respondents were categorized as follows: low stress: those who scored 0–13 on stress questions; moderate stress: those who scored 14–26 on stress questions; and high perceived stress: those who scored 27–40 on stress questions [34,35].

In this study, multiple comorbidities were defined as the presence of two or more chronic medical conditions in a single patient. The total number of comorbidities per patient was recorded, and descriptive statistics including range and median were calculated. We also explored whether certain combinations of comorbidities were associated with increased psychological distress.

Data processing, management and analysis

Data consistency and completeness were checked before an attempt was made to enter the code and analyse the data. All questionnaires were checked for completeness at the time of data collection. No missing data occurred for the main outcome variables (PSS-10-C, HADS, Oslo-3). Minimal missing values (<1%) in socio-demographic variables were handled using complete-case analysis.

Data were coded and entered using SPSS (statistical package software for social science) version 25.0 for statistical analysis. STATA 14.1 was also used for data analysis. All of the data were checked for completeness, and internal consistency was also checked to assess the reliability, which gave a Cronbach’s alpha = 0.783 for perceived stress scale, and Cronbach’s alpha = 0.9 for Hospital anxiety depression scale, which showed good internal consistency for this study. The descriptive analyses of data were presented using numerical summary measures, and the normal distribution of the studied variables was checked, showing that they were normally distributed. Different assumptions were checked prior to performing each statistical analysis. The test of parallel line was checked for ordinal logistic regression. Linear relationship between logarism of the dependent variable and continuous independent variables and multicollinearity were checked for binary logistic regression. The data were presented as frequency tables.

During preliminary data assessment, standard 10-year age intervals were initially considered; however, some of these intervals contained very small numbers of participants. To ensure adequate cell sizes and stable parameter estimates in both ordinal and binary logistic regression models, adjacent age groups were merged. This resulted in the final age categories used in the analysis: 18–38, 39–50, 51–62, and >62.

ordinal logistic regression was used to determine the relationship between perceived stress level and the independent variables; Binary logistic regression analysis with odds ratio along with 95% confidence interval was used to assess the degree of association anxiety and depression had with the independent variables. In bi-variable analysis, variables which have significant association with the dependent variables with p-value of less than 0.25 were entered into multivariate analysis model. This threshold is commonly used in epidemiological studies to reduce the risk of excluding potentially important predictors. A sensitivity analysis using a stricter selection criterion (p < 0.10) was also conducted, and the results remained consistent, confirming the robustness of the variable selection procedure.

Multicollinearity was assessed using Variance Inflation Factor (VIF), tolerance statistics, and Pearson correlation coefficients for continuous variables. Initial diagnostics showed strong multicollinearity among age, duration of illness, and age at onset; therefore, age at onset was excluded from the final models. All remaining variables demonstrated acceptable multicollinearity levels, with VIF values < 5 and tolerance > 0.2. Model diagnostics were also conducted to assess overall fit. For the binary logistic regression models, the Hosmer–Lemes how goodness-of-fit test (p > 0.05), Akaike Information Criterion (AIC), and Nagelkerke pseudo-R² values were examined. For the ordinal logistic regression model, the proportional odds assumption was confirmed through the test of parallel lines (p > 0.05), indicating that the ordinal model was appropriate (S1 Table).

Multivariate logistic regression models using adjusted odds ratios (AORs) were then applied to identify factors associated with psychological outcomes. Statistical significance was declared at p < 0.05, and the strength of associations was expressed using AORs with their respective 95% confidence intervals.

Result

Socio-demographic characters of participant patients

The data were collected from a total of 426 voluntary patients attending follow up at the outpatient department in selected tertiary Hospitals, Addis Ababa with response rate of 97.4%. The mean age of the participants was 49.57 years (SD ± 15.11 years). Of all participants, 222(52.1%) were females and nearly two-third of participants (68.1%) were currently married. Majority of participants (68.5%) reside in Addis Ababa; 195(45.8%) had more than four families living with them; 107(25.1%) lived in a single room; 90(21.1%) can’t read or write, 233(54.7%) were primary care giver for children or other relatives, and 120(28.2%) were housewives by occupation (Table 1).

Table 1. Socio-demographic characteristic of participant patients at OPD, Addis Ababa, Ethiopia, July 2021.

S. No Variables Category Number Percent
1 Age of participants 18-38 109 25.6
39-50 119 28
51-62 97 22.8
>62 100 23.5
2 Sex Male 204 47.9
Female 222 52.1
3 Marital status Currently married 290 68.1
Currently not married 136 31.9
4 Place of residence Outside Addis Ababa 134 31.5
Addis Ababa 292 68.5
5 Occupation House wife 120 28.2
Employed 154 36.2
Unemployed 115 27
Others 37 8.7
6 Educational level Can’t read or write 90 21.1
Primary 103 24.2
Secondary 109 25.6
Tertiary 124 29.1
7 Family size of the participant patients 1-4 231 54.2
>4 195 45.8
8 Being primary care giver for family members Yes 233 54.7
No 193 45.3
9 Number of rooms in the house 1 107 25.1
2 119 27.9
>2 200 46.9

Clinical characters and risk assessments of participant patients

Of all study participants, 175 (41.1%) had hypertension; 127 (29.8%) had chronic heart disease (CHD); 125 (29.3%) had diabetes mellitus (DM); 83 (19.5%) had cancer; 81 (19%) had chronic kidney disease (CKD); and 74 (17.4%) had chronic respiratory disease (CRD). Among the participants, 199 (47.3%) had been living with their chronic condition for more than five years, and 205 (48.7%) had an age at illness onset greater than 42 years.

In terms of COVID-19 risk assessment, 50 (11.7%) reported respiratory symptoms, and 65 (15.3%) did not use hand sanitizer. Additionally, 85 (20%) lacked social support in case of isolation or quarantine due to COVID-19. About 290 (68.1%) engaged in physical activity, while 12 (2.8%) reported current substance use. Poor social support was observed in 40.4% of participants (Table 2).

Table 2. Clinical characteristics and risk assessment of participant patients at OPD, Addis Ababa, Ethiopia, July 2021.

S. No Variables Category Number Percent
1 Type of chronic disease CKD 81 19
hypertension 175 41.1
cancer 83 19.5
diabetics 125 29.3
CHD 127 29.8
CRD 74 17.4
Others 15 3.5
2 Number of comorbidities 1 228 53.5
>1 198 46.5
3 Age of onset of illness <31 105 24.9
31-41 111 26.4
>42 205 48.7
4 Duration of illness ≤5 years 222 52.7
>5 199 47.3
5 Presence of respiratory symptoms Yes 50 11.7
No 375 88.3
6 Contact history Yes 44 10.3
No 382 89.7
No 85 20
7 Having social support if infected with COVID-19 Yes 341 80
No 85 20
8 Use of mask Yes 426 100
9 Use of sanitizer Yes 361 84.7
No 65 15.3
10 Physical activity Yes 290 68.1
No 136 31.9
11 Substance use Yes 12 2.8
No 414 97.2
12 number of people who are so close to you that you can count on them if you have great personal problems none 24 5.6
1-2 191 44.8
3-5 96 22.5
5+ 115 27
13 level of much interest and concern people show in what you do none 90 21.1
little 26 6.1
uncertain 19 4.5
some 52 12.2
a lot 239 56.1
14 How easy is it to get practical help from neighbors if you should need it Very difficult 181 42.5
Difficult 33 7.7
Possible 39 9.2
Easy 52 12.2
Very easy 121 28.4
15 Strength of social support Poor 172 40.4
Moderate 125 29.3
Strong 129 30.3

Regarding comorbidity, among the study participants, 198 (46.5%) had multi-morbidity. The number of chronic diseases per patient ranged from 1 to 4, with a median of 1. The most common comorbidity pattern was the coexistence of hypertension and diabetes mellitus (S2 Table).

Prevalence of perceived stress, anxiety and depression among participants patients with comorbidity

The mean perceived stress score of the respondents was 24.19 (±9.36SD). About 45.5% (95% CI: 40.85-50.31) of the respondents reported severe stress levels, 42.3% (95% CI: 37.63–47.02) reported moderate stress levels, and 12.2% (95% CI: 9.41–15.69) reported low COVID-19 related perceived stress levels.

Accordingly, the prevalence of depression and anxiety during COVID-19 pandemic among patients with comorbidities were 39.7% (95% CI: 35.11-44.42) and 26.5% (95% CI: 22.53-30.94), respectively. These prevalence estimates include both borderline and abnormal cases. The mean depression and anxiety scores were 7.31 ± 5.36 (ranging 0–21) and 5.99 ± 4.91 (ranging 0–21), respectively.

Regarding the level of depression and anxiety, the majority of respondents reported abnormal depression (28.6%) and anxiety (18.1%) level; whereas borderline depression and anxiety was reported in 11% and 8.5% of the patients respectively. These results are detailed in Table 3, which shows both the combined “Yes” category (borderline + abnormal) and the separate levels for transparency. This ensures that the overall reported prevalence (39.7% depression, 26.5% anxiety) corresponds to the sum of borderline + abnormal cases (Table 3).

Table 3. Prevalence of psychological problems among participant patients at OPD, Addis Ababa, Ethiopia, July 2021.

S. No Variables Status Number Percent Level Number Percent
1 Perceived stress level Low 52 12.2
Moderate 180 42.3
High 194 45.5
2 Anxiety Yes 113 26.5 normal 313 73.5
Borderline 36 8.5
No 313 73.5 abnormal 77 18.1
3 Depression Yes 169 39.7 normal 257 60.3
Borderline 47 11
No 257 60.3 abnormal 122 28.6

Note: The “Yes” category for depression and anxiety includes participants with either borderline or abnormal symptoms as defined by the HADS. Percentages for borderline and abnormal levels are reported separately for transparency.

Associated factors with perceived stress related to COVID -19 among patients with comorbidity

In the bivariate analysis, age, sex, marital status, educational status, occupation, place of residence, number of rooms in the house, CKD, CHD, chronic respiratory illness, diabetics, number of comorbidities, duration of illness, having social support if infected with COVID-19, respiratory symptoms, physical activity and social support were selected for multivariable analysis with p value less than 0.25. Age, marital status, place of residence, diabetics, number of comorbidities, physical activity and social support were selected for the final multivariable ordinal logistic regression model. In the final model, age, place of residence, number of comorbidities, physical activity and social support were significantly associated.

The odds of having high perceived stress compared to moderate perceived stress, low perceived stress is 9.3(95%CI: 4.80, 18.10), 12.7(95%CI: 6.70, 23.95) and 6.1(95%CI: 3.30, 11.30) times greater in those who belong to age groups 18–38, 39–50 and 51–62, respectively compared to those who belong to age group of 63 and above. The odds of having high perceived stress compared to moderate perceived stress, low perceived stress is 1.6(95%CI: 1.03, 2.50) times greater in those who lived in Addis Ababa compared to those who lived outside Addis Ababa. The odds of having high perceived stress compared to moderate perceived stress, low perceived stress is 1.7(95%CI: 1.10, 2.70) times greater in those who had more than one comorbidity compared to those who had only one comorbidity. The odds of having high perceived stress compared to moderate perceived stress, low perceived stress is 1.9(95%CI: 1.20, 2.90) times greater in those who are physically active compared to those who are not. The odds of having high perceived stress compared to moderate perceived stress, low perceived stress is 3.2(95%CI: 1.90, 5.20) and 1.7(95%CI: 1.02, 2.80) times greater in those who had poor and moderate social support, respectively compared to those who had strong social support (Table 4).

Table 4. Associated factors with perceived stress level due to COVID-19 among participant patients at OPD, Addis Ababa, Ethiopia, July 2021.

variable Perceived stress COR, 95%CI AOR, 95%CI P-value
Low Moderate Severe
Age
18-38 6 40 63 12.1(6.60,22.40) 9.3(4.80,18.10) 0.000
39-50 3 39 77 16.8(9.10,30.95) 12.7(6.70,23.95) 0.000
51-62 7 45 45 7.7(4.20,14.20) 6.1(3.30,11.30) 0.000
>62 35 56 9 1.00
Residence
Out of Addis Ababa 24 65 45 1.00
Addis Ababa 28 115 149 2.1(1.40,3.10) 1.6(1.04,2.50) 0.033
Current marital status
Currently married 43 138 109 1.00
Currently not married 9 42 85 2.7(1.80,4.10) 1.4(0.90,2.30) 0.134
Diabetics
No 36 119 146 1.00
Yes 16 61 48 0.7(0.50,1.10) 0.8(0.50,1.30) 0.313
Number of comorbidities
1 30 102 96 1.00
>1 22 78 98 1.3(0.90,1.90) 1.7(1.10,2.70) 0.016
Respiratory symptoms
No 50 160 166 1.00
Yes 2 20 28 1.7(0.99,3.10) 1.5(0.80,2.80) 0.227
Physical activity
No 25 58 53 1.00
Yes 27 122 141 1.6(1.10,2.40) 1.9(1.20,2.90) 0.005
Social support
Poor 10 57 105 3.9(2.50,6.30) 3.2(1.90,5.20) 0.000
Moderate 13 62 50 1.8(1.10,2.90) 1.7(1.02,2.80) 0.042
Strong 29 61 39 1.00

Associated factors with depression among the patients with comorbidity

In the bivariate analysis, age, sex, marital status, educational status, occupation, being primary care giver for children or other relatives, number of rooms in the house, CKD, hypertension, cancer, diabetics, CHD, number of comorbidities, duration of illness, physical activity and social support were selected for multivariable analysis with p value less than 0.25. Age, marital status, educational status, being primary care giver for children or other relatives, diabetics, CHD, number of comorbidities and social support were selected for the final multivariable logistic regression model using backward LR method. In the final model, age, current marital status, educational status, diabetics, CHD, number of comorbidities and social support were significantly associated with depression.

The odds of having depression among those who belong to age groups 18–38 and 39–50 were 2.8(95% CI: 1.20–50) and 2.6(95% CI: 1.30-5.30) times higher respectively compared to those who belong to age group 63 years and above. The odds of having depression among those who are currently not married were 1.8(95% CI: 1.04–2.95) times higher compared to those who are married. The odds of having depression among those who can’t read or write were 2.14 (95% CI: 1.09–4.17) times higher compared to those who completed college and above. Respondents with the lifetime history of diabetes and CHD had 0.5 times the (95% CI: 0.30–0.90) odds of developing depression than those with no history of diabetes and CHD. Respondents with more than one comorbidity had 3.2 times the (95% CI: 1.90–5.40) odds of developing depression than those with only one comorbidity. Respondents with poor social support had 3.7 times the (95% CI: 2.20–6.50) odds of developing depression than those with strong social support (Table 5).

Table 5. Associated factors with depression among participant patients at OPD, Addis Ababa, Ethiopia, July 2021.

Variable Depression COR, 95%CI AOR, 95%CI P-value
Yes No
Age
18-38 53 56 3.36(1.83-6.14) 2.78(1.20-5.00) 0.009
39-50 59 60 3.49(1.93-6.32) 2.60(1.27-5.30) 0.009
51-62 35 62 2.00(1.07-3.75) 1.40(0.67-2.80) 0.409
>62 22 78 1.00
Current marital status
Currently married 97 193 1.00
Not married 72 64 2.24(1.48-3.39) 1.80(1.04-2.95) 0.035
Educational status
Can’t read or write 41 49 1.52(0.87-2.65) 2.14(1.09-4.17) 0.025
Primary 43 60 1.30(0.76-2.23) 1.20(0.70-2.30) 0.511
Secondary 41 68 1.09(0.64-1.87) 1.00(0.50-1.80) 0.990
Tertiary 44 80 1.00
Being primary care giver
No 67 126 1.00
Yes 102 131 1.46(0.99-2.17) 1.40(0.80-2.20) 0.225
Diabetics
No 128 173 1.00
Yes 41 84 1.52(0.98-2.35) 0.50(0.30-0.90) 0.018
Cardiac
No 126 173 1.00
Yes 43 84 0.11(0.46-1.08) 0.50(0.30-0.90) 0.012
Number of comorbidities
1 76 152 1.00
>1 93 105 1.77(1.19-2.62) 3.20(1.90-5.40) 0.000
Social support
Poor 101 71 4.91(2.94-8.19) 3.70(2.20-6.50) 0.000
Moderate 39 86 1.56(0.89-2.74) 1.50(0.80-2.70) 0.227
Strong 29 100 1.00

Associated factors with anxiety among the patients with comorbidity

In the bivariate analysis, age, sex, marital status, occupation, residence, being primary care giver for children or other relatives, number of rooms in the house, CKD, diabetics, chronic respiratory illness, number of comorbidities, duration of illness and social support were selected for multivariable analysis with p value less than 0.25. Age, sex, marital status, being primary care giver for children or other relatives, number of comorbidities and social support were selected for the final multivariable logistic regression model using backward LR method. In the final model, age, sex, being primary care giver for children or other relatives, number of comorbidities and social support were significantly associated with anxiety.

The odds of having anxiety among those who belong to age group 18–38 were 2.6(95% CI: 1.10–5.99) times higher compared to those who belong to age group 63 years and above. The odds of having anxiety among females were 2.04(95% CI: 1.24–3.37) times higher compared to males. Further, the odds of having anxiety among those who are primary care giver for children or other relatives were 1.88(95% CI: 1.10–3.20) times higher compared to those who are not the primary care giver. Respondents with more than one comorbidity had 1.8 times the (95% CI: 1.11–2.98) odds of developing anxiety than those with only one comorbidity. Lastly, respondents with poor and moderate social support had 3.9(95% CI: 2.04–7.45) and 2.3(95% CI: 1.12–4.64) times the odds of developing anxiety than those with strong social support respectively (Table 6).

Table 6. Associated factors with anxiety among participant patients at OPD, Addis Ababa, Ethiopia, July 2021.

variable Anxiety COR, 95%CI AOR, 95%CI P-value
Yes No
Age
18-38 37 72 4.63(2.15-9.93) 2.57(1.10-5.99) 0.029
39-50 39 80 4.39(2.06-9.36) 2.26(0.98-5.20) 0.056
51-62 27 70 3.47(1.58-7.65) 1.99(0.86-4.66) 0.110
>62 10 90 1.00
Sex
Male 36 168 1.00
Female 77 145 2.48(1.57-3.90) 2.04(1.24-3.37) 0.005
Current marital status
Currently married 62 228 1.00
Currently not married 51 85 2.21(1.41-3.45) 1.63(0.94-2.82) 0.08
Being primary care giver
No 39 154 1.00
Yes 74 159 1.84(1.18-2.87) 1.88(1.09-3.21) 0.022
Number of comorbidities
1 51 177 1.00
>1 62 136 1.58(1.03-2.44) 1.82(1.11-2.98) 0.017
Social support
Poor 68 104 4.97(2.68-9.23) 3.89(2.04-7.45) 0.000
Moderate 30 95 2.40(1.22-4.72) 2.28(1.12-4.64) 0.023
Strong 15 114 1.00

Model diagnostics

The logistic regression models demonstrated acceptable goodness-of-fit. The Hosmer–Lemeshow test was non-significant (p > 0.05), indicating that the model fit the data adequately. Model explanatory power was also acceptable, with a Nagelkerke pseudo-R² of 0.637 in the unadjusted model and 0.629 after adjustment. The Akaike Information Criterion (AIC) was used to compare alternative model specifications, with the final model showing the lowest AIC value.

For the ordinal logistic regression model assessing perceived stress levels (low, moderate, high), the proportional odds assumption was met, as indicated by a non-significant test of parallel lines (p > 0.05). This confirmed that the ordinal regression model was appropriate for the analysis.

Disscusion

In the context of a pandemic, the perceived “threat” can be ubiquitous, potentially carried by anyone in close proximity. From a psychopathological perspective, the COVID-19 pandemic constitutes a relatively novel form of stressor or trauma [36]. Findings from this study clearly demonstrate that the psychological well-being of individuals with comorbidities may be adversely affected by the pandemic and its associated psychosocial consequences. Elevated levels of perceived stress, anxiety, and depression have been consistently linked to the ongoing public health crisis.

The data for this study were collected during the early post–first-wave phase of COVID-19 in Ethiopia, a period marked by high case numbers in April 2021, followed by a gradual decline, with limited vaccine coverage. This context may have intensified psychological distress among chronic patients due to heightened uncertainty, fear of infection, and disruptions in routine healthcare services. Because of these conditions, the levels of stress, anxiety, and depression observed in this study may differ from those measured in later pandemic phases—such as after broader vaccination or improved health-system stability. Nonetheless, the findings offer important insights into mental health vulnerabilities during acute public-health crises and remain relevant for guiding post-pandemic mental health support strategies.

A majority of the patients reported moderate to severe levels of perceived stress due to the pandemic, accounting for 42.3% and 45.5%, respectively. This finding aligns with a study conducted in southwest Ethiopia [34], but it is higher than results reported in studies conducted among the general population in Gondar, China, and Turkey [3740]. The observed variation may be attributed to differences in study populations, as individuals with chronic illnesses tend to experience significantly higher levels of psychological distress. Additionally, the disruption of routine healthcare services for chronic conditions during the COVID-19 outbreak may have served as a persistent source of stress for these patients. Conversely, the reported stress levels in this study were lower than those observed in a similar study conducted in Tigray [34], possibly reflecting disparities in the socioeconomic and political contexts between the two regions. The findings were also lower than those reported in a study from India involving patients undergoing hemodialysis [40], a population known to experience elevated stress levels due to both socioeconomic pressures and ongoing health challenges. Although common stressors associated with chronic illness can be empirically identified, notable differences exist across conditions in terms of the type and severity of stress experienced. Treatment-related demands, such as daily medication adherence, frequent dialysis sessions, and lifestyle restrictions, combined with the inability to fulfill previous social roles, represent significant sources of psychological burden for many patients [41].

It was observed that 39.6% of the patients exhibited depressive symptoms, while 26.6% reported anxiety symptoms during the COVID-19 pandemic. These findings are lower than those reported at Mettu Karl Referral Hospital in Ethiopia, where the prevalence of depression and anxiety among patients with chronic medical conditions was higher [28]. This discrepancy may be attributed to differences in study settings and populations, including variations in literacy levels, socioeconomic status, and access to specialized medical care. The disproportionate economic impact of the pandemic and challenges in accessing healthcare services may have also contributed to the differing outcomes. Additionally, the lower prevalence observed in the current study may be influenced by social desirability bias. Compared to pre-pandemic data, the prevalence of depression in this study (39.6%) is notably higher than the 5.73% reported prior to COVID-19 [42]. Conversely, the prevalence of anxiety (26.6%) is lower than the 32% reported among patients with chronic medical conditions in Ethiopia before the onset of the pandemic [42]. These variations could be due to differences in study populations, socio-cultural contexts, or the measurement tools used to assess psychological outcomes. Social desirability bias may also partially explain the lower reported rates in the current study. Furthermore, the prevalence of depression and anxiety in the current sample was higher than that reported among the general population in Gondar [37], which is likely due to differences in study populations, as the previous study was conducted among the general public rather than patients with chronic illnesses. In contrast, the current findings are lower than those reported among patients with chronic and immunocompromising conditions in Saudi Arabia during the COVID-19 pandemic [42], and in other studies involving patients with chronic illnesses [43]. These differences may reflect variations in study settings, cultural and political contexts, and the instruments used to assess depression and anxiety.

This study identified several demographic and clinical factors associated with increased levels of COVID-19-related psychological distress among patients with chronic medical conditions. Notably, individuals aged 62 and above reported significantly lower levels of perceived stress compared to younger age groups. Similar findings have been reported in studies from Iran, where higher stress levels were observed among individuals aged 21–40 [15], likely due to economic uncertainty, job instability, and increased exposure to distressing information via social media among younger populations [44,45]. Additionally, older adults may be more accustomed to staying at home, resulting in less disruption to their daily routines during periods of mandatory self-isolation [34]. In contrast, studies from Ethiopia and Turkey reported higher stress levels among older adults [34,39] possibly reflecting regional differences in healthcare access and the availability of social support systems.

The finding that nearly half of the participants had multiple comorbidities underscores the complexity of managing chronic diseases during the COVID-19 pandemic. Participants residing in Addis Ababa reported significantly higher levels of perceived stress compared to those living outside the city. Moreover, individuals with multiple comorbidities experienced greater stress than those with a single chronic condition, likely reflecting increased health risks, limited access to medications, and heightened vulnerability to severe COVID-19 outcomes [34].

Among the study population, certain comorbidity combinations—particularly hypertension and diabetes mellitus, were associated with the highest stress levels. In this study, multi-morbidity was operationally defined as the presence of two or more chronic conditions, with the number of conditions per patient ranging from 1 to 4 and a median of 1. These findings highlight the importance of identifying high-risk comorbidity profiles to guide the development of targeted mental health interventions for patients with chronic illnesses during the pandemic.

Interestingly, patients who reported engaging in physical activity had higher levels of perceived stress, a finding that contrasts with most existing literature, which generally shows that physical activity reduces stress. This may reflect reverse causation, where more stressed patients intentionally increased their physical activity as a coping strategy. Additionally, the study did not differentiate between types, intensity, or context of physical activity, and some activities (such as outdoor or occupational exercise) might have increased perceived exposure risk to COVID-19, thereby raising stress. This unexpected association warrants further investigation to clarify contextual or measurement influences.

Those with poor or moderate social support also had higher stress levels, potentially driven by fears of isolation or dying alone. These factors can exacerbate anxiety, stress, and depressive symptoms, particularly during public health crises.

Younger people were found to be at higher risk of depression, which aligns with studies from the UK and Iran [44,46]. Depression was also more common among those who were widowed, divorced, or single, possibly due to reduced social support and feelings of loneliness [46]. People with lower levels of education faced a higher risk of depression as well, likely linked to financial struggles and economic stress [46]. Interestingly, a study from Iran showed the opposite: individuals with higher education reported more depression, which might be due to greater awareness and concern about the situation [44].

Depression and anxiety were more common among patients with multiple comorbidities [37,44,47,48] and those lacking strong social support, in line with findings from Ethiopia, Iran, and China [28,44,49]. These results highlight the added psychological burden experienced by individuals with complex medical conditions and limited emotional support.

Female gender was significantly associated with higher levels of anxiety during the pandemic, consistent with findings from studies conducted in Iran, the UK, and Saudi Arabia [42,44,46].

Younger age also emerged as a strong predictor of anxiety, as supported by multiple international studies [42,44,46]. Additionally, being a primary caregiver was linked to increased anxiety, likely due to heightened concern for the well-being of dependents. Similarly, a study from Iran found that individuals living with children experienced higher levels of anxiety compared to those living with other adults [46].

Overall, the findings of this study align with existing literature, underscoring the psychological vulnerability of younger individuals, women, and patients with multiple comorbidities or limited social support during the COVID-19 pandemic. Targeted psychosocial interventions are crucial for these high-risk groups to reduce the risk of long-term mental health consequences.

Handling multicollinearity was important to ensure valid estimates in the regression analyses. Age, age at onset of illness, and duration of illness demonstrated very high correlations, and therefore age at onset was removed from the final models to improve model stability. This adjustment strengthened the reliability of the regression results and ensured that individual predictors contributed meaningfully to the overall model.

The acceptable results of the goodness-of-fit tests further support the validity of the models. The proportional odds assumption for the ordinal regression model was met, indicating that perceived stress levels followed a consistent pattern across predictor categories. Together, these diagnostic procedures confirmed that the models used were appropriate and yielded interpretable findings regarding psychological outcomes among chronic patients during the COVID-19 pandemic.

Limitations of the study

This cross-sectional study cannot establish temporal relationships, and reliance on self-reported data may have introduced inaccuracies and social desirability bias. Data collection relied on interviewer-administered questionnaires, as many chronic-disease patients were older adults with limited literacy, making self-administered questionnaires impractical. While this ensured comprehension and inclusion, it may have increased the risk of social desirability bias, potentially leading to under reporting of psychological symptoms. Interviewers were trained to maintain neutrality, ensure confidentiality, and encourage honest responses, and the questionnaire included validation items to improve reliability. The use of only quantitative methods without qualitative triangulation limited deeper understanding of participants’ perspectives. Additionally, patients with severe mental health issues who may have stopped attending hospitals could have been missed, possibly underestimating the prevalence of mental health problems. Research design and researcher bias might have influenced outcomes. Given the fluctuating nature of pandemic-related mental health impacts, longitudinal studies are needed to better capture these changes over time.

We acknowledge that multiple statistical comparisons were performed in this study without formal correction for multiple testing. This may increase the likelihood of Type I errors; therefore, the findings, particularly those approaching significance, should be interpreted with caution. Further research with larger samples and confirmatory analyses is recommended to validate these results.

This study has notable limitations related to selection bias. First, excluding critically ill patients and those experiencing acute exacerbations may have led to underestimation of psychological distress, as individuals in acute crisis often experience heightened anxiety and stress. However, we made this exclusion intentionally because acute medical episodes, such as DKA, HHS, or severe asthma/COPD exacerbations, are themselves powerful psychological stressors that would make it difficult to isolate the mental health impact attributable specifically to the COVID-19 pandemic. Second, the exclusion of patients with pre-existing mental health conditions likely also contributed to underestimation of the true prevalence of distress, as these individuals may have been more vulnerable during the pandemic. In addition, our sample included only patients who continued to attend outpatient clinics, meaning that individuals who avoided care due to fear, financial constraints, or severe psychological distress were not captured.

We lacked data on participants’ or family members’ COVID-19 infection status, income loss, employment disruption, family deaths, healthcare disruptions (e.g., missed appointments), detailed socioeconomic indicators (e.g., household income), access-to-care variables (e.g., travel distance, granular residence), and chronic disease duration/severity—all of which may influence psychological outcomes. Substance use prevalence (2.8%) is likely underestimated due to social desirability bias, and 100% reported mask use probably reflects reporting bias. The term “primary caregiver” is defined in Methods as main responsibility for day-to-day care of a dependent household member. Finally, protective factors (resilience, coping strategies, religious/spiritual support) were not assessed. Future studies should address these gaps by collecting comprehensive pandemic-related, socioeconomic, clinical, and protective factor data.

Finally, because the study was conducted in two tertiary referral hospitals in the capital city, generalizability to rural populations or lower-level health facilities is limited.

Conclusion

The COVID-19 pandemic has exacerbated psychological distress among patients with chronic comorbidities in Addis Ababa, with high prevalence of perceived stress, depression, and anxiety observed. Younger age, multiple comorbidities, poor social support, and female gender were key factors associated with increased mental health burden. These findings highlight the urgent need for targeted psychosocial interventions and support services tailored to vulnerable groups. Given the study’s cross-sectional nature, further longitudinal research is essential to better understand the evolving mental health impact of the pandemic on this high-risk population.

Supporting information

S1 Table. Assessment of multicollinearity among independent variables.

(XLSX)

pgph.0005838.s001.xlsx (10.8KB, xlsx)
S2 Table. Distribution of comorbidities among study participants.

(XLSX)

pgph.0005838.s002.xlsx (10.8KB, xlsx)
S1 Data. Dataset.

(XLSX)

pgph.0005838.s003.xlsx (150.8KB, xlsx)

Acknowledgments

I sincerely thank my advisors for their invaluable guidance. I am grateful to the staff and administration at Yekatit 12 Hospital, Tikur Anbessa Specialized Hospital, and Saint Paul’s Hospital Millennium Medical College, as well as the patients who participated in this study.

Special thanks to Ms. Kalkidan Dege, Ms. Yordanos Dege, Mr. Ananiya Tilahun, Dr. Maraki Mehari, Dr. Amanuel Asres, Dr. Tewodros Haile, and Dr. Muluken Tesfaye for their valuable support and advice.

Lastly, I deeply appreciate my family and friends for their unwavering encouragement.

Data Availability

You can access the updated dataset and supplemental materials through the following link: https://doi.org/10.6084/m9.figshare.31143931.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Biadgilign S, Yigzaw M. COVID-19 in Ethiopia: current situation, missed opportunities, and the risk of health system disruptions. Pan Afr Med J. 2020;35(Suppl 2):66. doi: 10.11604/pamj.supp.2020.35.2.23906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ethiopian Public Health Institute EPHI. Home-based isolation and care for COVID-19 patients: Summary update. 2020. [Google Scholar]
  • 3.Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines. 2020;6:16. doi: 10.1186/s40794-020-00118-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Yohannes AM. COPD patients in a COVID-19 society: depression and anxiety. Expert Rev Respir Med. 2021;15(1):5–7. doi: 10.1080/17476348.2020.1787835 [DOI] [PubMed] [Google Scholar]
  • 5.Leulseged TW, Abebe KG, Hassen IS, Maru EH, Zewde WC, Chamiso NW, et al. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center. PLoS One. 2022;17(1):e0262896. doi: 10.1371/journal.pone.0262896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069–76. doi: 10.1007/s42399-020-00363-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Saladino V, Algeri D, Auriemma V. The Psychological and Social Impact of Covid-19: New Perspectives of Well-Being. Front Psychol. 2020;11:577684. doi: 10.3389/fpsyg.2020.577684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gregucci F, Caliandro M, Surgo A, Carbonara R, Bonaparte I, Fiorentino A. Cancer patients in Covid-19 era: Swimming against the tide. Radiother Oncol. 2020;149:109–10. doi: 10.1016/j.radonc.2020.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Singhai K, Swami MK, Nebhinani N, Rastogi A, Jude E. Psychological adaptive difficulties and their management during COVID-19 pandemic in people with diabetes mellitus. Diabetes Metab Syndr. 2020;14(6):1603–5. doi: 10.1016/j.dsx.2020.08.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49(2):124–38. doi: 10.1177/070674370404900208 [DOI] [PubMed] [Google Scholar]
  • 11.Kivimäki M, Batty GD, Kawachi I, Steptoe A. The Routledge International Handbook of Psychosocial Epidemiology. Abingdon: Routledge; 2017. [Google Scholar]
  • 12.Matte DL, Pizzichini MMM, Hoepers ATC, Diaz AP, Karloh M, Dias M, et al. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154–61. doi: 10.1016/j.rmed.2016.06.006 [DOI] [PubMed] [Google Scholar]
  • 13.Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2000;15(12):1090–6. doi: [DOI] [PubMed] [Google Scholar]
  • 14.Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547–60. doi: 10.1016/S2215-0366(20)30168-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Guan D, Wang D, Hallegatte S, Davis SJ, Huo J, Li S, et al. Global supply-chain effects of COVID-19 control measures. Nat Hum Behav. 2020;4(6):577–87. doi: 10.1038/s41562-020-0896-8 [DOI] [PubMed] [Google Scholar]
  • 16.Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi: 10.1001/jamanetworkopen.2020.14780 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yeh GY, Horwitz R. Integrative Medicine for Respiratory Conditions: Asthma and Chronic Obstructive Pulmonary Disease. Med Clin North Am. 2017;101(5):925–41. doi: 10.1016/j.mcna.2017.04.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Khatib R, Schwalm J-D, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238. doi: 10.1371/journal.pone.0084238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Elran-Barak R, Mozeikov M. One Month into the Reinforcement of Social Distancing due to the COVID-19 Outbreak: Subjective Health, Health Behaviors, and Loneliness among People with Chronic Medical Conditions. Int J Environ Res Public Health. 2020;17(15):5403. doi: 10.3390/ijerph17155403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018;361:k1415. doi: 10.1136/bmj.k1415 [DOI] [PubMed] [Google Scholar]
  • 21.Chudasama YV, Gillies CL, Zaccardi F, Coles B, Davies MJ, Seidu S, et al. Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020;14(5):965–7. doi: 10.1016/j.dsx.2020.06.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ghebremichael ST, Tewolde RH, Andegiorgish AK, Pan G. The Pattern of COVID-19 in Horn of Africa countries, from March-December 2020. Afr Health Sci. 2023;23(1):108–19. doi: 10.4314/ahs.v23i1.13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Musah A, Musah G. Financial development, public health financing, and health outcomes in Sub-Saharan Africa. 2024;1–15. [DOI] [PMC free article] [PubMed]
  • 24.Ali M, Debela M, Bamud T. Technical efficiency of selected hospitals in Eastern Ethiopia. Health Econ Rev. 2017;7(1):24. doi: 10.1186/s13561-017-0161-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Grazioli E, Cerulli C, Dimauro I, Moretti E, Murri A, Parisi A. New strategy of home-based exercise during pandemic COVID-19 in breast cancer patients: a case study. Sustainability. 2020;12(15):5940. doi: 10.3390/su12155940 [DOI] [Google Scholar]
  • 26.United Nations Security Council. Letter dated 12 March 2021 from the President of the Security Council addressed to the Secretary-General and the Permanent Representatives of the members of the Security Council. Document S/2021/201. New York: United Nations; 2021. [Google Scholar]
  • 27.Kassaw C. The Magnitude of Psychological Problem and Associated Factor in Response to COVID-19 Pandemic Among Communities Living in Addis Ababa, Ethiopia, March 2020: A Cross-Sectional Study Design. Psychol Res Behav Manag. 2020;13:631–40. doi: 10.2147/PRBM.S256551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hajure M, Tariku M, Mohammedhussein M, Dule A. Depression, Anxiety and Associated Factors Among Chronic Medical Patients Amid COVID-19 Pandemic in Mettu Karl Referral Hospital, Mettu, Ethiopia, 2020. Neuropsychiatr Dis Treat. 2020;16:2511–8. doi: 10.2147/NDT.S281995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ambaw F. The structure and reliability of the amharic version of the hospital anxiety and depression scale in orphan adolescents in addis ababa. Ethiop J Health Sci. 2011;21(1):27–35. doi: 10.4314/ejhs.v21i1.69041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Reda AA. Reliability and validity of the Ethiopian version of the hospital anxiety and depression scale (HADS) in HIV infected patients. PLoS One. 2011;6(1):e16049. doi: 10.1371/journal.pone.0016049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopoulou P, Kalemi G, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008;7:4. doi: 10.1186/1744-859X-7-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Abiola T, Udofia O, Muhammed Z. Psychometric properties of the 3-item Oslo Social Support Scale among clinical students of Bayero University Kano, Nigeria. Afr J Psychiatry (Johannesbg). 2013;16(3):201–5. doi: 10.4314/ajpsy.v16i3.1623739823 [DOI] [Google Scholar]
  • 33.Kocalevent R-D, Berg L, Beutel ME, Hinz A, Zenger M, Härter M, et al. Social support in the general population: standardization of the Oslo social support scale (OSSS-3). BMC Psychol. 2018;6(1):31. doi: 10.1186/s40359-018-0249-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Adhena G, Temesgen T. Perceived stress associated with COVID-19 pandemic in Korem, Tigray, Ethiopia: community-based cross-sectional study. Sci J Public Health. 2022;8(6):289–96. [Google Scholar]
  • 35.Pedrozo-Pupo JC, Campo-Arias A. Depression, perceived stress related to COVID, post-traumatic stress, and insomnia among asthma and COPD patients during the COVID-19 pandemic. Chron Respir Dis. 2020;17:1479973120962800. doi: 10.1177/1479973120962800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Fiorillo A, Gorwood P. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur Psychiatry. 2020;63(1):e32. doi: 10.1192/j.eurpsy.2020.35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Akalu TY, Gelaye KA, Bishaw MA, Tilahun SY, Yeshaw Y, Azale T, et al. Depression, Anxiety, and Stress Symptoms and Its Associated Factors Among Residents of Gondar Town During the Early Stage of COVID-19 Pandemic. Risk Manag Healthc Policy. 2021;14:1073–83. doi: 10.2147/RMHP.S296796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020;17(5):1729. doi: 10.3390/ijerph17051729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Altunta O. Effect of COVID-19 on perceived stress, coping skills, self-control and self-management skills. Int J Psychol Behav Sci. 2020;10(3):45–60. [Google Scholar]
  • 40.Shinde M, Mane SP. Stressors and the coping strategies among patients undergoing hemodialysis. Int J Health Sci Res. 2014;4(9):111–26. [Google Scholar]
  • 41.Jejaw M, Tafere TZ, Tiruneh MG, Hagos A, Teshale G, Tilahun MM, et al. Three in four children age 12-23 months missed opportunities for vaccination in Sub-Saharan African countries: a multilevel mixed effect analysis of demographic health and surveys 2016-2023. BMC Public Health. 2025;25(1):62. doi: 10.1186/s12889-024-21273-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Edmealem A, Olis CS. Factors Associated with Anxiety and Depression among Diabetes, Hypertension, and Heart Failure Patients at Dessie Referral Hospital, Northeast Ethiopia. Behav Neurol. 2020;2020:3609873. doi: 10.1155/2020/3609873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kaya Y, Bostan S, Kaya A, Karaman Ö, Karataş A, Dereli S. Effect of COVID-19 pandemic on anxiety depression and intention to go to hospital in chronic patients. Int J Clin Pract. 2021;75(7):e14219. doi: 10.1111/ijcp.14219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16(1):57. doi: 10.1186/s12992-020-00589-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Erlich H. Three Revolutions. Greater Tigray and the Mysterious Magnetism of Ethiopia. Oxford University Press; 2024. p. 137–54. doi: 10.1093/oso/9780197769331.003.0011 [DOI] [Google Scholar]
  • 46.Abraham A, Yakob T, Dawit D, Ashiko A, Tekese D, Israell E. One out of every three adult TB patients suffered from undernutrition in conflict affected Southern Ethiopia: a multicenter facility-based cross-sectional study. Front Epidemiol. 2025;5:1405845. doi: 10.3389/fepid.2025.1405845 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382–6. doi: 10.15585/mmwr.mm6913e2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Clemente-Suárez VJ, Dalamitros AA, Beltran-Velasco AI, Mielgo-Ayuso J, Tornero-Aguilera JF. Social and Psychophysiological Consequences of the COVID-19 Pandemic: An Extensive Literature Review. Front Psychol. 2020;11:580225. doi: 10.3389/fpsyg.2020.580225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Han B, Yan B, Zhang J, Zhao N, Sun J, Li C, et al. The influence of the social support on symptoms of anxiety and depression among patients with silicosis. ScientificWorldJournal. 2014;2014:724804. doi: 10.1155/2014/724804 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005838.r001

Decision Letter 0

Theingi Maung Maung

8 Dec 2025

PGPH-D-25-03264

Prevalence and Determinants of Depression, Anxiety, and Perceived Stress Among Patients with Chronic Comorbidities Attending Outpatient Clinics in Addis Ababa During the COVID-19 Pandemic

PLOS Global Public Health

Dear Dr. Negash,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 22 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Theingi Maung Maung, Ph.D

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. We have amended your Competing Interest statement to comply with journal style. We kindly ask that you double check the statement and let us know if anything is incorrect.

2. Please provide separate figure files in .tif or .eps format.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirements

3. Your manuscript is missing the following sections: Discussion. Please ensure these are present, and in the correct order, and that any references to subheadings in your main text are correct. An outline of the required sections can be consulted in our submission guidelines here:

https://journals.plos.org/globalpublichealth/s/submission-guidelines#loc-parts-of-a-submission

4. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The paper deals with a significant issue of the mental health effects of COVID-19 on chronic conditions in Ethiopia. The research is overall well-constructed and offers useful information on a population that is not much studied. Nevertheless, there are a number of methodological and presentation concerns that should be resolved before publication.

1. The data were collected between April- June 2021, which is almost four years ago. Although the authors do not dismiss this as a cross-sectional study, there is little information on the impact of the pandemic phase of data collection (post-initial wave, pre-vaccination in Ethiopia) on the generalizability. The discussion must be clear:

• . What is the stage of the pandemic in this?

• The way the findings could vary in other phases of the pandemic.

• The applicability of these results to mental health assistance following the pandemic.

2. The criterion of the exclusion of critically ill patients or patients with acute exacerbation can be a great source of selection bias. Psychological distress may be the greatest in patients who have acute exacerbations. The authors should:

• . Measure the number of patients who were not included for this reason.

• Talk about how this omission may result in the underestimation of prevalence.

• This is one of the significant weaknesses in generalizability.

3. Social desirability bias is cited as one of the possible limitations by the authors, but it is not fully dealt with. Considering the nature of face-to-face interviews and the culture:

• What did interviewers do to reduce this bias?

• Did it contain validation questions?

• Did the authors ever think of using anonymous self-administered questionnaires?

4. The paper gives 46.5% as having had multiple comorbidities, but Table 3 presents a lot of patients with their conditions overlapping. Please clarify:

• What was the method of counting multiple comorbidities (e.g., a patient with hypertension, diabetes, and heart disease = 3 conditions)?

• What was the range, median number of comorbidities?

• Was it that some of the combinations were more closely linked with psychological distress?

5.

a) Multivariate Model Variable Selection: The authors selected p<0.25 in bivariate analysis to select the variables. Although this method is common, it might have irrelevant variables. Could you explain why this threshold was chosen, and this should be analyzed by sensitivity analysis with p<0.10.

b) Multicollinearity: The authors state that they have verified the presence of multicollinearity, although they do not provide the values of VIF. Since there is a likelihood of correlation between age, duration of illness, and age at onset, please provide:

• Final models of VIFs of all variables.

• Continuous variable correlation matrix.

c) Model Fit Statistics No goodness-of-fit statistics are provided on the logistic regression models (e.g., Hosmer-Lemeshow test, AIC, pseudo-R 2). These should be included.

d) Ordinal Logistic Regression: Did proportional odds assume low/moderate/high levels of perceived stress? The authors state that they do the test of parallel lines, but they do not give the results.

6. The fact that stress was reported higher among physically active patients (AOR=1.9, p=0.005) is counterintuitive and should be given some more consideration. The concise explanation of the authors (an increased risk of exposure) is speculative. Consider:

• Is this reverse causation (stressed patients working out to get better)?

• Were there variations in kinds of physical activity?

• This observation is contrary to the literature, and it requires more in-depth investigation.

7. Figure 1 indicates k=7, though it is referred to as systematic random sampling. Please explain whether k was different by clinic or not.

• The rate of respondents was very good (97.4), and what about the 11 non-responders? Were they systematically dissimilar?

8. The PSS-10-C is said to be pandemic-related, but we should verify [34, 35]. Was this particularly confirmed in Ethiopia regarding COVID-19?

9. The Cronbach alpha of PSS-10-C is not high but satisfactory (0.783). Bad item-total correlations?

a) Table 1 & 3 (this should be Table 2): The numbering of the table seems wrong. The second table is actually Table 3 on page 15.

b) Age Categories: The age categories (18-38, 39-50, 51-62, >62) do not seem to be arbitrary. What was the rationale? It is better to use common age groups (e.g., 10-year intervals) to make the study more comparable to others.

c) Missing Data: No discussion of missing data. Are there any declined responses? How were they handled?

10. The abstract indicates severe stress (45.5%), depression (39.7%), and anxiety (26.5%).

11. Table 5 (Table 12 in the list), however, displays the depression and anxiety as yes/no, but also by level.

12. In their reporting of depression at 39.7, is this combined with borderline (11%) + abnormal (28.6)? Please clarify throughout.

13.

a) Comparison with Pre-pandemic Data: You compare with a pre-pandemic Ethiopian study [42], but it would be nice to see more pre-pandemic Ethiopian baseline data in the discussion, provided that it exists.

b) Clinical Implications: The prevalence and determinants have received much discussion, although little guidance is given on:

• Which particular interventions can be performed in the conditions of resource limitation?

• What is the way of incorporating mental health screening into chronic disease clinics?

• What are the implications of the health system?

c) Contradictory Results: In the age and stress discussion, you have support of younger adults experiencing higher stress (Iran) and older adults experiencing higher stress (Ethiopia, Turkey). The discussion will be enhanced by increasingly questioning why you have found a correlation with certain studies rather than others.

14. The limitations are properly recognized; however, the limitations are to be added with:

• Absence of pre-pandemic baseline data for the same patients.

• Failure to determine the status of COVID-19 infection or loss of family and loved ones.

• None of the past mental health history (not within treatment).

• One-point assessment in a dynamic pandemic.

• Page 4: "2740% of patients with chronic obstructive lung disease (COPD)- initial mention, COPD needs to be spelled out completely, followed by the abbreviation.

• Page 5: the lifestyle modifications should be lifestyle modifications.

• Page 6: please spell out (Gregorian Calendar?) GC on June 30, 2021GC

• Unstable abbreviations: OPD vs outpatient department.

15. You identified scores as poor (3-8), moderate (9-11), and strong (12-14). Nonetheless, only 3 items will be rated on a scale of 1-5, so it should be 15 instead of 14. Please confirm that your scoring system is equivalent to your references [32, 33]. The discussed methods are the ways to evaluate environmental, socio-economic, and health-related issues related to COVID-19, although these data are not provided in the results. Were these collected? In that case, they would be a useful context.

16. You have applied 55.7% prevalence in [28] and at the same time 22.8% in [27]. Why choose 55.7%? A smaller sample would be required to make a more conservative estimate. This move has to be explained.

Essential Revisions:

• The numbering of tables is correct.

• Explain the count of multiple comorbidities and give descriptive statistics.

• All regression model fit statistics Report models.

• Give VIF values to show that there is no multicollinearity.

• Be more expansive on the context of the time and the generalizability.

• Discuss the physical activity paradox in more detail.

• Include clinical, health system implications in the discussion.

• Be more specific on how selection bias can be a problem.

• Add information on COVID-19-related stressors in case they were gathered.

• Take into consideration stratified analysis based on the type of chronic condition.

Reviewer #2: General Comments

This study addresses an important topic regarding the mental health impact of COVID-19 on patients with chronic comorbidities in Ethiopia. The research is timely and contributes to understanding vulnerable populations during the pandemic. However, there are several limitations and areas requiring clarification or improvement.

Major Limitations and Concerns

1. Temporal Validity and Relevance

Data collection period (April-June 2021) represents a specific pandemic phase that may not reflect current or evolving mental health impacts

The cross-sectional design captures only a snapshot during one pandemic wave, limiting understanding of how psychological distress evolved over time

Consider acknowledging that findings may be specific to that pandemic period and discussing how mental health trajectories may have changed since

2. Selection Bias and Generalizability

Exclusion of patients with pre-existing mental health conditions creates significant selection bias. These patients likely experienced the most severe psychological impact during COVID-19, yet they were systematically excluded

This exclusion means your prevalence estimates are likely underestimates of the true burden

The sample includes only patients who continued attending outpatient clinics. Patients who stopped seeking care due to fear, financial constraints, or severe psychological distress were missed

Both hospitals are tertiary referral centers in the capital city, limiting generalizability to rural populations or secondary healthcare settings

3. Social Desirability Bias

You acknowledge this limitation but do not discuss its potential magnitude

Face-to-face interviews may have led participants to underreport psychological symptoms, particularly in a culture where mental health stigma exists

Self-administered questionnaires might have reduced this bias

4. Lack of Comparison Group

No pre-pandemic baseline data for the same population

No concurrent control group (e.g., patients without chronic conditions or general population)

This makes it difficult to attribute findings specifically to the pandemic versus chronic illness burden alone

5. Causality and Temporal Relationships

The cross-sectional design precludes establishing whether chronic conditions preceded or followed mental health symptoms

Cannot determine if COVID-19 stress caused the observed mental health outcomes or if pre-existing distress was simply measured during the pandemic

Methodological Concerns Requiring Clarification

6. Sampling and Response Rate

While you report a 97.4% response rate (426/437), this seems exceptionally high for voluntary participation in mental health research

Please clarify: Were patients approached consecutively? How many refused before the interview began?

The systematic sampling assumes all eligible patients attended during the study period—how did you handle missed appointments or irregular attendance patterns?

7. Multiple Comorbidities and Disease Complexity

46.5% had multiple comorbidities, but the analysis doesn't account for specific comorbidity combinations

Different chronic disease combinations may have differential psychological impacts (e.g., cancer + CKD vs. hypertension + diabetes)

Disease severity and functional status were not assessed

8. Measurement Issues

PSS-10-C (COVID-specific perceived stress):

You report using PSS-10-C but provide limited validation information for the Ethiopian context

Was this tool translated and validated specifically for Amharic speakers?

The cut-off of ≥27 for "high stress" needs better justification—is this validated in your population?

HADS:

While validated in Ethiopian populations, most citations refer to HIV patients or adolescents—different from your chronic disease population

Cultural adaptation details are missing

Oslo-3:

Very brief measure (3 items) of a complex construct

May not capture pandemic-specific changes in social support networks

9. Statistical Analysis Concerns

Multicollinearity: You mention checking for it but don't report VIF values or tolerance statistics

Model fit statistics: No goodness-of-fit indices reported for logistic regression models

Multiple testing: With numerous comparisons, no correction for multiple testing is mentioned (though this may be acceptable in exploratory research)

Effect sizes: Only odds ratios presented—consider reporting standardized effect sizes for better interpretability

10. Missing Pandemic-Specific Variables

No assessment of COVID-19 infection history among participants or family members

Vaccination status not captured (though this may predate widespread vaccination in Ethiopia)

No measure of pandemic-related losses (income, employment, family deaths)

Healthcare disruption not quantified (missed appointments, delayed treatments)

Minor Limitations and Suggestions

11. Incomplete Characterization of Sample

Median household income or poverty indicators not reported

Distance traveled to hospital not assessed (relevant for access and stress)

Urban vs. rural origin within "outside Addis Ababa" not differentiated

Specific chronic disease duration and severity not detailed

12. Physical Activity Paradox

Your finding that physically active patients had higher stress (AOR=1.9) is counterintuitive and inadequately explained

Was this possibly reverse causation (anxious patients exercising more to cope)?

Physical activity assessment appears to be a simple yes/no—intensity, duration, and type not captured

13. Data Quality Concerns

2.8% substance use seems very low for a population under stress—possible underreporting

100% mask use is suspiciously high—suggests social desirability bias

Some variables (e.g., "being primary caregiver") are not clearly defined

14. Limited Exploration of Protective Factors

Study focuses primarily on risk factors

Resilience, coping strategies, and positive adaptation not assessed

Religious/spiritual support not evaluated despite mentioning religious festival restrictions as stressors

15. Language and Presentation

Some repetition between results and discussion sections

Tables could be streamlined (Table 2 is very long)

Statistical notation inconsistencies (CI presentation varies)

Recommendations for Authors

For Discussion Section:

More explicitly address the selection bias from excluding patients with pre-existing mental health conditions and those who stopped attending clinics

Discuss the physical activity paradox more thoroughly—this is a surprising finding that needs explanation

Acknowledge that prevalence estimates are likely conservative due to multiple sources of underestimation

Expand discussion of cultural context—how might Ethiopian cultural norms around mental health expression have influenced findings?

Provide more context on healthcare system disruptions in Ethiopia during this period

For Limitations Section:

The current limitations section is brief. Consider expanding to include:

Selection bias from excluding patients with mental health conditions

Inability to distinguish pandemic-specific effects from chronic illness burden

Lack of pre-pandemic baseline or control group

Potential social desirability bias in face-to-face interviews

Limited generalizability to rural populations and lower-level health facilities

Snapshot nature of cross-sectional data during one pandemic phase

Unmeasured confounders (disease severity, functional status, economic impact)

For Future Research Recommendations:

Longitudinal studies tracking mental health trajectories

Inclusion of patients with pre-existing mental health conditions

Mixed-methods research incorporating qualitative data

Intervention studies testing psychosocial support programs

Comparison with pre-pandemic cohorts

Assessment of long-term mental health consequences

Specific Questions for Authors

Why were patients with pre-existing mental health conditions excluded? This seems to exclude the most vulnerable group.

Can you provide validation data for PSS-10-C in the Ethiopian context?

How did you handle patients with multiple comorbidities in the analysis? Were interaction effects explored?

What was the refusal rate before consent? The 97.4% response rate seems unusually high.

Can you explain the counterintuitive finding regarding physical activity and increased stress?

Were any interventions offered to patients identified with severe depression, anxiety, or stress?

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Dr. Jonah Bawa Adokwe

Reviewer #2: Yes:  Tooba Adil

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005838.r003

Decision Letter 1

Theingi Maung Maung

30 Dec 2025

Prevalence and Determinants of Depression, Anxiety, and Perceived Stress Among Patients with Chronic Comorbidities Attending Outpatient Clinics in Addis Ababa During the COVID-19 Pandemic

PGPH-D-25-03264R1

Dear Dr Negash,

We are pleased to inform you that your manuscript 'Prevalence and Determinants of Depression, Anxiety, and Perceived Stress Among Patients with Chronic Comorbidities Attending Outpatient Clinics in Addis Ababa During the COVID-19 Pandemic' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Theingi Maung Maung, Ph.D

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

publication criteria?>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: I recommend acceptance for publication.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Dr. Jonah Bawa Adokwe

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Assessment of multicollinearity among independent variables.

    (XLSX)

    pgph.0005838.s001.xlsx (10.8KB, xlsx)
    S2 Table. Distribution of comorbidities among study participants.

    (XLSX)

    pgph.0005838.s002.xlsx (10.8KB, xlsx)
    S1 Data. Dataset.

    (XLSX)

    pgph.0005838.s003.xlsx (150.8KB, xlsx)
    Attachment

    Submitted filename: 3. Response to Reviewers.docx

    pgph.0005838.s005.docx (56.8KB, docx)

    Data Availability Statement

    You can access the updated dataset and supplemental materials through the following link: https://doi.org/10.6084/m9.figshare.31143931.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES